These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24098990)

  • 1. Recombinant cancer vaccines and new vaccine targets. Interview by Jenaid Rees.
    Schlom J
    Expert Rev Vaccines; 2013 Oct; 12(10):1121-4. PubMed ID: 24098990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer vaccines: looking to the future. Interview by Jenaid Rees.
    Apostolopoulos V
    Expert Rev Vaccines; 2013 Oct; 12(10):1125-6. PubMed ID: 24093953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer vaccines in the immunotherapy era: rational approach.
    Kim DS
    Hum Vaccin Immunother; 2013 Sep; 9(9):2017-8. PubMed ID: 23831824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First person: Arlene Sharpe, MD, PhD: Scientist's work on PD-1 pathway paves the road to key cancer immunotherapies.
    Printz C
    Cancer; 2018 Oct; 124(19):3795-3796. PubMed ID: 30412303
    [No Abstract]   [Full Text] [Related]  

  • 6. Interview with Professor Angus Dalgleish.
    Dalgleish A
    Immunotherapy; 2016 Nov; 8(11):1271-1276. PubMed ID: 27993091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapeutics: evolution of monoclonal antibodies to peptide immunogens.
    Murali R; Kieber-Emmons T
    Monoclon Antib Immunodiagn Immunother; 2014 Jun; 33(3):179-82. PubMed ID: 24892996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour.
    Haseltine WA
    Regen Med; 2011 Jul; 6(4):431-5. PubMed ID: 21749201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interview: An interview with Chad Mirkin: nanomedicine expert. Interviewed by Hannah Stanwix.
    Mirkin C
    Nanomedicine (Lond); 2012 May; 7(5):635-8. PubMed ID: 22630148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvants: the future is bright. Interview by Jenaid Rees.
    Rappuoli R
    Expert Rev Vaccines; 2013 Jul; 12(7):727-9. PubMed ID: 23829664
    [No Abstract]   [Full Text] [Related]  

  • 12. Interview. Cancer vaccines and immunotherapy of autoimmune diseases.
    Apostolopoulos V
    Immunotherapy; 2009 Jan; 1(1):15-7. PubMed ID: 20635968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood.
    Giannoukakis N
    Immunotherapy; 2013 Sep; 5(9):919-21. PubMed ID: 23998726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interview with Margaret A Liu: the future of gene-based vaccines and immunotherapies, and other musings.
    Liu MA; Rees J
    Expert Rev Vaccines; 2015 Feb; 14(2):157-9. PubMed ID: 25474286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leading the way in biomedical engineering: an interview with Robert Langer. Interview by Hannah Stanwix, Commissioning Editor.
    Langer R
    Nanomedicine (Lond); 2012 Oct; 7(10):1483-4. PubMed ID: 23148539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanostructures for sensors and analytical systems.
    Craighead H
    Nanomedicine (Lond); 2012 Mar; 7(3):317-9. PubMed ID: 22385195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination therapy in malignant disease.
    Aloysius MM; Robins RA; Eremin JM; Eremin O
    Surgeon; 2006 Oct; 4(5):309-20. PubMed ID: 17009550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Life achievements of Dr. Dusan Kentera (1925-1999). Aspects of pulmonary circulation].
    Susić D
    Srp Arh Celok Lek; 2003; 131(3-4):189-98. PubMed ID: 14608887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portrait of Dr Michael G. Hanna, Jr. A pioneer in active specific immunotherapy of cancer.
    Hanna M
    Hum Vaccin Immunother; 2014; 10(7):1778-80. PubMed ID: 25424782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Excellence in the Cards?
    McPoil TG
    Phys Ther; 2019 Oct; 99(10):1281-1290. PubMed ID: 31665788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.